Results 1 to 10 of about 8,266 (211)

Minoxidil in trichological practice [PDF]

Медицинский совет, 2018
Management of patients with alopecia is still a challenging task. Minoxidil is a pyrimidine derivative, a potent KATP channel opener, and has been shown to act as a vasodilating agent.
O. Yu. Olisova, I. P. Gostroverkhova
doaj   +2 more sources

Successful management of suspected minoxidil toxicosis in a cat following accidental dermal exposure

Veterinární Medicína, 2022
Minoxidil was originally introduced as a potent vasodilator, but is now widely used as a topical treatment for human alopecia. A 4-year-old neutered male Norwegian Forest cat presented with a 2-day history of anorexia, lethargy, and dyspnoea.
Song JH, Kim SY, Moon JH, Jung DI
doaj   +1 more source

Minoxidil Skin Delivery from Nanoemulsion Formulations Containing Eucalyptol or Oleic Acid: Enhanced Diffusivity and Follicular Targeting

Pharmaceutics, 2018
In this work, we examined enhanced skin delivery of minoxidil applied in nanoemulsions incorporating skin penetration enhancers. Aliquots of fully characterized oil-in-water nanoemulsions (1 mL), containing minoxidil (2%) and the skin penetration ...
Eman Abd, Heather A. E. Benson, Michael S. Roberts, Jeffrey E. Grice   +3 more
doaj   +1 more source

New Target for Minoxidil in the Treatment of Androgenetic Alopecia

Drug Design, Development and Therapy, 2023
Yuqing Shen,1 Yuqi Zhu,1 Li Zhang,1 Jiayi Sun,1 Bo Xie,2 Hongyan Zhang,2 Xiuzu Song2 1Department of Dermatology, Hangzhou Third People’s Hospital, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Dermatology ...
Shen Y, Zhu Y, Zhang L, Sun J, Xie B, Zhang H, Song X   +6 more
doaj  

Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia

Dermatology and Therapy, 2023
Introduction This study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA) and analyzed the factors associated with minoxidil discontinuation.
Zari Shadi
doaj   +1 more source

Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting

ChemEngineering, 2021
Soluplus (Sol) is an amphiphilic graft copolymer capable of forming self-assembled micelles and L-ascorbyl 2,6-dipalmitate (ASC-DP) aggregates spontaneously to form micelles.
Rina Takayama, Moe Ishizawa, Miyuki Yamada, Yutaka Inoue, Ikuo Kanamoto   +4 more
doaj   +1 more source

Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia

Dermatologica Sinica
Background: The first-line pharmacologic treatment for both male and female pattern hair loss is topical minoxidil. Nonetheless, off-label usage of low-dose oral minoxidil has demonstrated good clinical efficacy and safety.
Bhumika Mahawar, Ashish Ramchandra Deshmukh   +1 more
doaj   +1 more source

Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis

Journal of Dermatological Treatment
Objective This systematic review evaluates the efficacy of minoxidil alone versus minoxidil with low-level laser therapy (LLLT) for androgenic alopecia.Study design systematic review and meta-analysis.Methods An online search of PubMed, Web of Science ...
Abdulmajeed Alosaimi, Abdullah Algarni, Abdulrahman Alharbi, Abdulmalik Alotaibi, Abdullah Alomairi, Mohannad Alsurayhi, Waleed Alharbi   +6 more
doaj   +1 more source

Short-Term Topical Minoxidil Use Associated with Acute Central Serous Chorioretinopathy: A Case Report

Case Reports in Ophthalmology
Introduction: Minoxidil is a topical, over-the-counter, FDA-approved drug used to treat male and female pattern hair loss. Three case reports were published associating long-term use of topical minoxidil to central serous chorioretinopathy ...
Jacob Brucker, Brian Mihok, Jeffrey Bloom   +2 more
doaj   +1 more source

Effect of High-Dose Topical Minoxidil on Erythrocyte Quality in SKH1 Hairless Mice

Animals, 2020
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have
Eduardo Naranjo-Vázquez, María Guadalupe Sánchez-Parada, Belinda Claudia Gómez-Meda, Ana Lourdes Zamora-Perez, Martha Patricia Gallegos-Arreola, Ana Elizabeth González-Santiago, Guillermo Moisés Zúñiga-González   +6 more
doaj   +1 more source